Nicotinamide Riboside

Category
nucleoside
Routes
Oral (PO)
Half-Life (t½)
PO: 1h
Formula
C11H15N2O5+
Molecular Weight
255.25 g/mol
PubChem CID
439924
Aliases
NR, Niagen, nad-precursor-nr, nr

Pharmacological Mechanism

NAD⁺ precursor — enters cells via ENT transporters, phosphorylated to NMN by NRK1/2, then adenylated to NAD⁺ by NMNAT. Smaller than NMN (no phosphate) so better cell entry. Raises whole-blood NAD⁺ ~40–60% at 300 mg/d in published RCTs.

Half-Life & Elimination Curve (PO: 1h)

100%50%25%12.5%0%0h0×t½1h1×t½2h2×t½3h3×t½4h4×t½5h5×t½0×t½ (0h): 100% remaining (~1.36 mg/L)1×t½ (1h): 50% remaining (~0.68 mg/L)2×t½ (2h): 25% remaining (~0.34 mg/L)3×t½ (3h): 12.5% remaining (~0.17 mg/L)4×t½ (4h): 6.3% remaining (~85 µg/L)5×t½ (5h): 3.1% remaining (~42.5 µg/L)
Plasma (PO)t½ Decay (1h)
  • 0×t½0h100% (1.36 mg/L)
  • 1×t½1h50% (0.68 mg/L)
  • 2×t½2h25% (0.34 mg/L)
  • 3×t½3h12.5% (0.17 mg/L)
  • 4×t½4h6.3% (85 µg/L)
  • 5×t½5h3.1% (42.5 µg/L)
Elimination t½1h (PO)
Rate Constant (ke)0.693 h⁻¹
Time to Peak (Tmax)49m
Est. Peak (Cmax)1.36 mg/L
Clearance (CL)24.3 L/h
97% Washout (5×t½)5h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Chemical Structure & Identifiers

References